Mapping utility scores from the EQ-5D and SF-6D onto the schizophrenia quality of life scale

被引：2
|
作者：
Clayson, DJ
Briggs, AH
Sculpher, M
De Hert, M
机构：
[1] Oxford Outcomes Ltd, Oxford, England
[2] Univ Oxford, Oxford OX1 2JD, England
[3] Univ York, York YO1 5DD, N Yorkshire, England
[4] Univ Centrum VZW, Centrum, Belgium
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62240-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：277 / 277
页数：1
相关论文
共 50 条
  • [1] Mapping the schizophrenia quality of life scale to EQ-5D, HUI3 and SF-6D utility scores in patients with schizophrenia
    Seow, Lee Seng Esmond
    Lau, Jue Hua
    Abdin, Edimansyah
    Verma, Swapna K.
    Tan, Kelvin Bryan
    Subramaniam, Mythily
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (07) : 813 - 821
  • [2] A Comparison of SF-6D and EQ-5D Utility Scores in a Study of Patients with Schizophrenia
    McCrone, P.
    Patel, A.
    Knapp, M.
    Schene, A.
    Koeter, M.
    Amaddeo, F.
    Ruggeri, M.
    Giessler, A.
    Puschner, B.
    Thornicroft, G.
    [J]. JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2009, 12 : S29 - S30
  • [3] A Comparison of SF-6D and EQ-5D Utility Scores in a Study of Patients with Schizophrenia
    McCrone, Paul
    Patel, Anita
    Knapp, Martin
    Schene, Aart
    Koeter, Maarten
    Amaddeo, Francesco
    Ruggeri, Mirella
    Giessler, Anne
    Puschner, Bernd
    Thornicroft, Graham
    [J]. JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2009, 12 (01): : 27 - 31
  • [4] Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia
    Abdin, Edimansyah
    Chong, Siow Ann
    Seow, Esmond
    Verma, Swapna
    Tan, Kelvin Bryan
    Subramaniam, Mythily
    [J]. QUALITY OF LIFE RESEARCH, 2019, 28 (01) : 177 - 186
  • [5] Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia
    Edimansyah Abdin
    Siow Ann Chong
    Esmond Seow
    Swapna Verma
    Kelvin Bryan Tan
    Mythily Subramaniam
    [J]. Quality of Life Research, 2019, 28 : 177 - 186
  • [6] COMPARISON OF THE SF-6D AND THE EQ-5D IN PATIENTS WITH SCHIZOPHRENIA
    Millier, A.
    Perthame, E.
    Aballea, S.
    Toumi, M.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A294 - A294
  • [7] Association between health-related quality of life and utility scores from EQ-5D or SF-6D in Crohn's disease
    Gerlier, L. C.
    Brown, M.
    Tan, S. C.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A358 - A358
  • [8] Association between health-related quality of life and utility scores from EQ-5D or SF-6D in Crohn's disease
    Feagan, Brian
    Tan, Seng
    Brown, Martin
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A475 - A475
  • [9] Scale Characteristics and Mapping Accuracy of the US EQ-5D, UK EQ-5D, and SF-6D in Patients with Rheumatoid Arthritis
    Wolfe, Frederick
    Michaud, Kaleb
    Wallenstein, Gene
    [J]. JOURNAL OF RHEUMATOLOGY, 2010, 37 (08) : 1615 - 1625
  • [10] The validity of estimating EQ-5D and SF-6D utility values from the HAP
    Harrison, Mark J.
    Lunt, Mark
    Bansback, Nick
    Verstapen, Suzanne
    Watson, Kath
    Symmons, Deborah
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S204 - S204
12345